IFNA1 and COVID-19: It has been reported that there is a strong type I interferons (IFN) response in the peripheral blood mononuclear cells of patients with SFTS and COVID-19, which plays a pivotal role in exacerbating hyperinflammation in fatal SFTS as well as severe COVID-19 [14, 15].